PDB Short entry for 1OL6 HEADER TRANSFERASE 06-AUG-03 1OL6 TITLE STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE KINASE 6; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 122-403; COMPND 5 SYNONYM: SERINE/THREONINE KINASE 15, AURORA/IPL1-RELATED KINASE 1, COMPND 6 AURORA-RELATED KINASE 1, HARK1, AURORA-A, BREAST-TUMOR-AMPLIFIED COMPND 7 KINASE; COMPND 8 EC: 2.7.1.37; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: CODONPLUS RIL; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PETM11 KEYWDS TRANSFERASE, CELL CYCLE, SERINE/THREONINE-PROTEIN KINASE, ATP- KEYWDS 2 BINDING, PHOSPHORYLATION EXPDTA X-RAY DIFFRACTION AUTHOR R.BAYLISS,E.CONTI REVDAT 5 13-DEC-23 1OL6 1 REMARK REVDAT 4 10-SEP-14 1OL6 1 SEQADV REVDAT 3 30-JAN-13 1OL6 1 HEADER KEYWDS JRNL REMARK REVDAT 3 2 1 VERSN FORMUL REVDAT 2 24-FEB-09 1OL6 1 VERSN REVDAT 1 30-OCT-03 1OL6 0 JRNL AUTH R.BAYLISS,T.SARDON,I.VERNOS,E.CONTI JRNL TITL STRUCTURAL BASIS OF AURORA-A ACTIVATION BY TPX2 AT THE JRNL TITL 2 MITOTIC SPINDLE. JRNL REF MOL.CELL V. 12 851 2003 JRNL REFN ISSN 1097-2765 JRNL PMID 14580337 JRNL DOI 10.1016/S1097-2765(03)00392-7 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 12265 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.277 REMARK 3 FREE R VALUE : 0.301 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1845 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 3 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.015 REMARK 3 BOND ANGLES (DEGREES) : 1.936 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OL6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-AUG-03. REMARK 100 THE DEPOSITION ID IS D_1290013228. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.30 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91839 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12265 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 58.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.16500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 3.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : 0.43200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1FOT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350, 190 MM NACL, 10 MM REMARK 280 NAH2PO4, 100 MM TRIS PH 7.3, PH 7.30 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.66500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.65500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.65500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.33250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.65500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.65500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 57.99750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.65500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.65500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 19.33250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.65500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.65500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 57.99750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 38.66500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED MUTATION ASP 274 ASN CHAIN A REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 122 REMARK 465 SER A 123 REMARK 465 LYS A 124 REMARK 465 LYS A 125 REMARK 465 ARG A 126 REMARK 465 GLN A 127 REMARK 465 GLY A 142 REMARK 465 GLY A 173 REMARK 465 VAL A 174 REMARK 465 ALA A 281 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 THR A 288 REMARK 465 LEU A 289 REMARK 465 CYS A 290 REMARK 465 GLY A 291 REMARK 465 ARG A 304 REMARK 465 LYS A 389 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 465 ASN A 392 REMARK 465 CYS A 393 REMARK 465 GLN A 394 REMARK 465 ASN A 395 REMARK 465 LYS A 396 REMARK 465 GLU A 397 REMARK 465 SER A 398 REMARK 465 ALA A 399 REMARK 465 SER A 400 REMARK 465 LYS A 401 REMARK 465 GLN A 402 REMARK 465 SER A 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 131 CG CD OE1 OE2 REMARK 470 LYS A 141 CG CD CE NZ REMARK 470 LYS A 143 CG CD CE NZ REMARK 470 ASN A 146 CG OD1 ND2 REMARK 470 ARG A 151 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 153 CG CD CE NZ REMARK 470 GLN A 154 CG CD OE1 NE2 REMARK 470 LYS A 156 CG CD CE NZ REMARK 470 PHE A 165 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 168 CG CD OE1 NE2 REMARK 470 GLU A 170 CG CD OE1 OE2 REMARK 470 LYS A 171 CG CD CE NZ REMARK 470 HIS A 176 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 177 CG CD OE1 NE2 REMARK 470 ARG A 179 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 ARG A 189 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 201 CG ND1 CD2 CE1 NE2 REMARK 470 ASP A 202 CG OD1 OD2 REMARK 470 THR A 204 OG1 CG2 REMARK 470 TYR A 207 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 220 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 227 CG CD CE NZ REMARK 470 GLN A 231 CG CD OE1 NE2 REMARK 470 ARG A 251 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 293 CG CD1 CD2 REMARK 470 GLU A 302 CG CD OE1 OE2 REMARK 470 MET A 305 CG SD CE REMARK 470 ASP A 307 CG OD1 OD2 REMARK 470 LYS A 326 CG CD CE NZ REMARK 470 ASN A 332 CG OD1 ND2 REMARK 470 TYR A 334 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 335 CG CD OE1 NE2 REMARK 470 THR A 337 OG1 CG2 REMARK 470 TYR A 338 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 339 CG CD CE NZ REMARK 470 ARG A 340 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 343 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 354 CG CD OE1 OE2 REMARK 470 ARG A 375 CG CD NE CZ NH1 NH2 REMARK 470 SER A 388 CA C O CB OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 307 N - CA - C ANGL. DEV. = 19.9 DEGREES REMARK 500 PRO A 368 C - N - CA ANGL. DEV. = 9.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 153 -5.04 -52.43 REMARK 500 LYS A 171 -36.77 -33.36 REMARK 500 GLU A 181 -79.97 -57.07 REMARK 500 VAL A 182 -55.62 -28.48 REMARK 500 ARG A 189 85.17 -154.80 REMARK 500 SER A 226 -35.65 68.71 REMARK 500 ASP A 256 51.98 -144.94 REMARK 500 ASN A 274 77.03 52.45 REMARK 500 GLU A 308 -23.83 -156.62 REMARK 500 PRO A 349 -152.64 -53.92 REMARK 500 LEU A 364 52.21 -92.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 1388 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MUO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE REMARK 900 RELATED ID: 1OL5 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND REMARK 900 BOUND TO TPX2 1-43 REMARK 900 RELATED ID: 1OL7 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287, THR288 DBREF 1OL6 A 122 403 UNP O14965 STK6_HUMAN 122 403 SEQADV 1OL6 ASN A 274 UNP O14965 ASP 274 ENGINEERED MUTATION SEQRES 1 A 282 GLU SER LYS LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU SEQRES 2 A 282 ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL SEQRES 3 A 282 TYR LEU ALA ARG GLU LYS GLN SER LYS PHE ILE LEU ALA SEQRES 4 A 282 LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY SEQRES 5 A 282 VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SER SEQRES 6 A 282 HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR SEQRES 7 A 282 PHE HIS ASP ALA THR ARG VAL TYR LEU ILE LEU GLU TYR SEQRES 8 A 282 ALA PRO LEU GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SEQRES 9 A 282 SER LYS PHE ASP GLU GLN ARG THR ALA THR TYR ILE THR SEQRES 10 A 282 GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SER LYS ARG SEQRES 11 A 282 VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU SEQRES 12 A 282 GLY SER ALA GLY GLU LEU LYS ILE ALA ASN PHE GLY TRP SEQRES 13 A 282 SER VAL HIS ALA PRO SER SER ARG ARG THR THR LEU CYS SEQRES 14 A 282 GLY THR LEU ASP TYR LEU PRO PRO GLU MET ILE GLU GLY SEQRES 15 A 282 ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SER LEU GLY SEQRES 16 A 282 VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE SEQRES 17 A 282 GLU ALA ASN THR TYR GLN GLU THR TYR LYS ARG ILE SER SEQRES 18 A 282 ARG VAL GLU PHE THR PHE PRO ASP PHE VAL THR GLU GLY SEQRES 19 A 282 ALA ARG ASP LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SEQRES 20 A 282 SER GLN ARG PRO MET LEU ARG GLU VAL LEU GLU HIS PRO SEQRES 21 A 282 TRP ILE THR ALA ASN SER SER LYS PRO SER ASN CYS GLN SEQRES 22 A 282 ASN LYS GLU SER ALA SER LYS GLN SER HET ATP A1388 31 HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 2 ATP C10 H16 N5 O13 P3 FORMUL 3 HOH *3(H2 O) HELIX 1 1 ALA A 129 PHE A 133 5 5 HELIX 2 2 LYS A 166 ALA A 172 1 7 HELIX 3 3 HIS A 176 LEU A 188 1 13 HELIX 4 4 THR A 217 SER A 226 1 10 HELIX 5 5 ASP A 229 SER A 249 1 21 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 THR A 292 LEU A 296 5 5 HELIX 8 8 PRO A 297 GLU A 302 1 6 HELIX 9 9 LYS A 309 GLY A 325 1 17 HELIX 10 10 THR A 333 ARG A 343 1 11 HELIX 11 11 THR A 353 LEU A 364 1 12 HELIX 12 12 MET A 373 GLU A 379 1 7 HELIX 13 13 HIS A 380 SER A 387 1 8 SHEET 1 AA 5 GLU A 134 GLY A 140 0 SHEET 2 AA 5 ASN A 146 ARG A 151 -1 O VAL A 147 N LEU A 139 SHEET 3 AA 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 AA 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 AA 5 LEU A 196 HIS A 201 -1 N TYR A 197 O ILE A 209 SHEET 1 AB 2 LEU A 262 LEU A 264 0 SHEET 2 AB 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 SITE 1 AC1 13 LEU A 139 GLY A 140 LYS A 141 LYS A 143 SITE 2 AC1 13 GLY A 145 VAL A 147 LYS A 162 LEU A 194 SITE 3 AC1 13 GLU A 211 ALA A 213 THR A 217 LEU A 263 SITE 4 AC1 13 ASN A 274 CRYST1 87.310 87.310 77.330 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011453 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011453 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012931 0.00000